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Key Clinical Message
Disseminated histoplasmosis among immunocompetent patients is rare, but
may be associated with clinically significant refractory thrombocytopenia. Plate-
let counts often return to normal levels following antifungal therapy. Therefore,
the most important management of this refractory thrombocytopenia is the
recognition and treatment of histoplasmosis infection.
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Case Presentation and Clinical
Reasoning
A 47-year-old man presented with a 6-week history of
episodic fevers associated with cramping abdominal pain.
Fevers occurred three times daily, were accompanied by
severe abdominal pain across the upper right and left
quadrants, and were followed by drenching sweats and
chills. The patient also complained of nausea, dry cough,
and an 18-kg weight loss during this time. Other than
cholecystectomy and knee ligament surgeries, the patient
had been previously healthy with no recent or recurrent
infections or known hematologic abnormalities. He was
adopted and had no information about the health of his
family members. He lived in Indiana and worked in an
office building near heavy construction. Four months
prior, he traveled to the Bolivian jungle for a fishing trip
where he consumed meat and was exposed to insects, but
did not swim or drink contaminated water.
The patient’s presentation with fevers, night sweats, and
weight loss over a 6-week period raises concern for a
chronic infection, malignant process, or rheumatologic
disease. His recent history of international travel makes
virulent tropical disease an important diagnostic considera-
tion in this previously healthy patient. Exposure to insects
raises suspicion for mosquito-borne or sandfly related dis-
eases such as malaria, dengue fever, chikungunya, or yellow
fever as well as visceral leishmaniasis. Consumption of
undercooked meat may cause trichinosis or toxoplasmosis,
conditions that may present with fever and abdominal pain.
Prior to the present admission, the patient had two
brief hospitalizations at another facility and underwent an
extensive infectious disease evaluation. Diagnostic tests
were performed for HIV infection, malaria, dengue fever,
chikungunya, hepatitis B and C, cytomegalovirus, and
Epstein–Barr virus, all of which were negative. Laboratory
results revealed elevated liver transaminases, which peaked
1 month before admission at our hospital (aspartate
aminotransferase [AST] 302 units/L, alanine aminotrans-
ferase [ALT] 517 units/L). A right upper quadrant ultra-
sound was unrevealing, and head computerized
tomography (CT) scan and cerebrospinal fluid analyses
were negative. Chest CT scan with contrast revealed
numerous bilateral pulmonary nodules and calcified
mediastinal and hilar lymph nodes (Fig. 1). An abdomi-
nal and pelvis CT scan with contrast showed moderate
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splenomegaly and trace ascites (Fig. 2). Given his imaging
findings, elevated liver transaminases, and history of
abdominal pain, he was referred to the hepatology service
at our hospital for further evaluation.
The patient’s unrevealing initial infectious disease eval-
uation in combination with bilateral pulmonary nodules
and calcified lymph nodes make sarcoidosis and granulo-
matous infections such as histoplasmosis, coccidioidomy-
cosis, and blastomycosis as well as tuberculosis important
considerations in this patient. Sarcoidosis may cause
granulomatous infiltration of the spleen and liver, leading
to elevated liver transaminases. Endemic fungal infections
also commonly involve the liver and spleen. Tuberculosis,
mycobacterium avium-intracellulare infection, visceral
leishmaniasis, and secondary syphilis may also cause gran-
ulomatous hepatitis.
On admission, the patient was afebrile and in mild dis-
tress, with no appreciable lymphadenopathy, petechiae, or
ecchymoses. Initial laboratory serum results were notable
for a WBC count of 3.2 k/cumm, with 65% neutrophils,
18% lymphocytes, and 13% monocytes, a hemoglobin
level of 11.7 g/dL, and a platelet count of 4 k/cumm.
Prothrombin and partial thromboplastin times were
normal. The peripheral blood smear revealed severe
thrombocytopenia with normal platelet morphology and
toxic granulation. Platelet-associated antibody screening
revealed 70% reactivity. Results also showed slightly ele-
vated lactate dehydrogenase (305 units/L, reference range
140–271 units/L) and elevated ferritin (1396 ng/mL),
lysozyme (14.8 lg/mL), and angiotensin-converting
enzyme (152 units/L). Liver transaminases were slightly
elevated (AST 52 units/L, ALT 58 units/L), and alkaline
phosphatase was also elevated (202 units/L).
The patient’s laboratory results reveal pancytopenia
with severe thrombocytopenia, as well as toxic granula-
tion on peripheral blood smear, suggestive of infectious
or inflammatory process. The patient’s elevated level of
angiotensin-converting enzyme makes sarcoidosis an
important diagnostic consideration, although elevated
levels may also be found in tuberculosis or endemic
mycoses. Markedly elevated ferritin in the setting of nor-
mal iron levels also suggests an acute or chronic inflam-
matory process or malignancy.
Fungal and mycobacterial studies were sent, and bone
marrow aspiration and biopsy were performed. The
Histoplasma capsulatum urine antigen, serum antigen, and
serum antibody test results were all positive. Bone mar-
row aspirate showed clusters of epithelioid histiocytes and
increased megakaryopoiesis with mild dysmegakary-
opoiesis (Fig. 3). Biopsy showed hypercellular bone mar-
row with scattered granulomata including epithelioid
histiocytes, lymphocytes, and plasma cells (Fig. 4A and
B). Acid-fast bacillus and Grocott’s methenamine silver
(GMS) stains were performed. The GMS stain showed
yeast forms (Fig. 4B and C), and the bone marrow cul-
ture was positive for H. capsulatum. The bone marrow
aspirate flow cytometry showed no evidence of malig-
nancy. The hematology team was consulted, and workup
for common variable immunodeficiency with quantitative
immunoglobulin levels was negative.
The dimorphic fungus H. capsulatum is found in soil
around the world, most commonly in South America and
Figure 1. Chest computerized tomography (CT) scan with contrast showing numerous bilateral pulmonary nodules (arrow: 1-cm nodule) and
calcified mediastinal and hilar lymph nodes (arrowhead: mediastinal lymph nodes).
Figure 2. Abdominal and pelvic CT scan with contrast revealing
moderate splenomegaly and trace ascites.
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the Ohio and Mississippi river valleys of the United States
[1]. While those living in endemic areas are exposed to
H. capsulatum at high rates, symptomatic infection is
uncommon. Clinical manifestations occur in <1% of
exposed persons and include acute pulmonary disease,
chronic cavitary disease, and disseminated disease [2].
Disseminated histoplasmosis is the rarest form of infec-
tion and typically presents with fever, malaise, weight loss,
and lymphadenopathy among immunosuppressed persons
[2]. While uncommon, disseminated disease does occur
in adults without any recognized immunologic deficits
and has been associated with a profound thrombocytope-
nia [3, 4].
Intravenous liposomal amphotericin 3 mg/kg/day was
started on day 2 of admission for 14 days. Itraconazole
200 mg twice daily was started on day 4 with instructions
to continue treatment for 1 year. The patient was no
longer febrile by day 4 and noted improvement in
strength and energy by day 6. While the white blood cell
count and hemoglobin level gradually increased starting
on day 7, the platelet count did not respond to several
platelet transfusions (Figs. 5 and 6). The patient initially
received two doses of 1 g/kg IV immunoglobulin (IVIG)
over 2 days with no improvement. Prior to discharge, the
platelet count finally stabilized around 10 k/cumm
(Fig. 5). Platelet count was monitored with serial checks
at the hematology clinic during the course of antifungal
treatment.
Corticosteroids were not administered as the patient
did not respond to IVIG, he was not actively bleeding,
and he had a severe disseminated histoplasmosis infec-
tion. It was also decided to hold further platelet transfu-
sions unless the platelet count dropped below 5 k/cumm
or in the case of bleeding, neither of which occurred.
One month following discharge, the H. capsulatum
urine antigen remained positive, but the patient reported
considerable clinical improvement with no further febrile
episodes or abdominal pain. His platelet count was
39 k/cumm at the time. Two months after discharge,
laboratory results showed a normalization of the platelet
Figure 3. Bone marrow aspirate with clusters of epithelioid histiocytes and increased megakaryocytes. Mildly increased megakaryopoiesis is best
shown in the middle image (209).
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count (221 k/cumm) and liver function tests. The H. cap-
sulatum urine antigen test was negative 5 months follow-
ing hospital discharge. The patient completed 1 year of
itraconazole therapy, and he experienced no treatment
side effects. The H. capsulatum urine antigen remained
negative 6 weeks following treatment cessation. The
(A) (B)
(C) (D)
Figure 4. (A) Bone marrow biopsy showing hypercellular bone marrow with scattered granulomata (arrows) and maturing trilineage
hematopoiesis (H&E stain, 2009). (B) Bone marrow biopsy with granuloma including epithelioid histiocytes, lymphocytes, and plasma cells (H&E
stain, 5009). (C) + (D) Scattered fungal forms (arrows) were seen in granulomatous foci (GMS stain, 10009).
Figure 5. Trend of platelet count throughout hospital stay.
Figure 6. Change in platelet count in relation to time after transfusion.
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patient returned to his baseline of functioning and has
remained healthy to date.
The patient’s thrombocytopenia was thought to be sec-
ondary to disseminated histoplasmosis, and he was dis-
charged from the hematology clinic. Liposomal
amphotericin B is recommended for severe cases of dis-
seminated histoplasmosis [1]. The lipid formulations
require 3–5 mg/kg/day, and the deoxycholate formula-
tions require a dose of 0.7–1.0 mg/kg/day. As in the case
of our patient, most patients respond quickly to ampho-
tericin B treatment and can be transitioned to itracona-
zole therapy. The ideal duration of itraconazole treatment
is currently not known, but therapy for at least 1 year
may reduce the risk of relapse infection.
Discussion
We report a case of disseminated histoplasmosis in a pre-
sumably immunocompetent male complicated by severe
thrombocytopenia. While disseminated disease typically
occurs in immunosuppressed patients, we found no evi-
dence of an immune deficiency and the patient has
remained healthy to date. Prior to disease onset, the
patient had been working in an office building adjacent
to a construction site. Heavy aerosol exposure to H. cap-
sulatum can produce an influenza-like syndrome of acute
pulmonary histoplasmosis [5]. Although the patient had
numerous bilateral pulmonary nodules and calcified
mediastinal and hilar lymph nodes on imaging, he
reported no recent respiratory infections. Even if the
patient experienced active pulmonary disease, deteriora-
tion into disseminated infection would still be uncommon
in an immunocompetent patient.
Although the patient lives in an area highly endemic
for H. capsulatum, he was not diagnosed with dissemi-
nated histoplasmosis for 6 weeks following the onset of
symptoms. His travel history to Bolivia complicated the
clinical picture, making a virulent tropical disease a diag-
nostic consideration in a previously healthy host. He
underwent an extensive evaluation for infectious diseases
before he was evaluated for histoplasmosis. Given that
untreated disseminated infection is progressive and can
be fatal over 2–12 weeks [1, 2], this case serves as an
important reminder that elements of the patient’s history
can be misleading. Making an accurate and timely diag-
nosis may involve disregarding salient features of the clin-
ical picture.
Our patient had severe thrombocytopenia that did not
respond to IVIG or platelet transfusions (Fig. 5). Although
rare, other cases of histoplasmosis complicated by refrac-
tory thrombocytopenia have been reported [3, 4, 6]. We
conducted a search in MEDLINE (from 1950) in order to
identify and summarize previously reported cases of
histoplasmosis associated with low platelet counts. We
used the terms “histoplasmosis,” “thrombocytopenia,” or
“pancytopenia” as Medical Subject Headings and searched
full-text article bibliographies to retrieve additional rele-
vant articles. We excluded nonhuman cases, pediatric
cases, articles not translated into English, and reports
among immunocompromised patients (e.g., patients with
HIV). The 13 articles fulfilling inclusion criteria are sum-
marized in Table 1. In total, 45 cases of histoplasmosis and
thrombocytopenia have been reported in immunocompe-
tent adults since 1950, including 21 from Vanderbilt
University Medical Center [5], 10 from the Christian Med-
ical College in India [7], four from the National Institutes
of Health Clinical Center [8], and 10 reports of individual
cases [3, 4, 6, 9–15]. Among these reports, demographics
and case details were provided for 14 patients; ages ranged
from 20 to 77 years (mean of 52), 11 patients (79%) were
male, nine (64%) had splenomegaly, and four (29%) died
from active histoplasmosis.
Three reported cases of thrombocytopenia were refrac-
tory to initial treatment [3, 4, 6]. Armitage and Sheets [3]
describe the case of a 41-year-old woman successfully
treated for disseminated histoplasmosis who developed
thrombocytopenia (platelet count 6 k/cumm) after a
month of amphotericin B therapy. A trial dose of pred-
nisone initially improved platelet counts to 100 k/cumm,
but steroids could not be weaned and the patient required
splenectomy. Kucera and Davis report the case of a 20-
year-old woman with pulmonary histoplasmosis, throm-
bocytopenia (platelet count: 5 k/cumm on admission)
refractory to platelet transfusions, and an elevated platelet
antibody level [6]. Following treatment for histoplasmosis,
the platelet counts improved without specific therapy and
platelet antibodies decreased to normal levels. Subbalaxmi
et al. describe the case of a 56-year-old man from India
with thrombocytopenia (platelet count: 10 k/cumm) and
bleeding manifestations. The platelet count continued to
drop despite transfusions on alternate days and improved
beginning on day 5 of treatment. In our case, the
patient’s platelet counts were refractory to treatment with
both IVIG and platelet transfusions. The platelet count
gradually increased until it normalized 2 months after ini-
tiation of antifungal therapy.
Several mechanisms have been postulated to contribute
to the thrombocytopenia resulting from a histoplasmosis
infection. First, with severe infection, H. capsulatum can
infiltrate the bone marrow and lead to thrombocytopenia,
along with anemia and leukopenia, due to impaired pro-
duction [8]. Second, in human plasma, H. capsulatum
can form a complex with IgG and fibrinogen and pro-
mote platelet aggregation and serotonin release [16].
Third, histoplasmosis may rarely induce immune
thrombocytopenic purpura (ITP), as evidenced by the
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immunocompetent patient with the delayed severe throm-
bocytopenia that responded to splenectomy [3]. Finally,
with disseminated infection, abnormal activation of the
coagulation system, as in disseminated intravascular coag-
ulation, may lead to consumption of platelets. In our
patient, as well as two other reported cases [4, 6], throm-
bocytopenia improved dramatically following successful
treatment of histoplasmosis. Although our patient had
evidence of H. capsulatum in the bone marrow,
megakaryocytes were present, suggesting that infiltration
of the bone marrow alone was likely not a sufficient
mechanism to cause such severe thrombocytopenia. Con-
sumption of platelets in an overfunctional immune sys-
tem and diffuse inflammatory state such as in this case is
possible. Our patient had a platelet-associated antibody
screening of 70%, and while this test has low specificity,
it implies an autoimmune mechanism for his severe
thrombocytopenia. There was a rapid destruction of the
transfused platelets as early as 2 hours posttransfusion,
which would also suggest an immune mechanism (Fig. 6).
The autoimmune response did not resolve until the
eradication of histoplasmosis, which suggests that the
infection was either directly or indirectly involved in
generating this response.
In summary, disseminated histoplasmosis among
immunocompetent patients is rare, but may be associ-
ated with clinically significant refractory thrombocytope-
nia. H. capsulatum can cause thrombocytopenia by
infiltrating bone marrow and affecting platelet produc-
tion, promoting platelet aggregation, or inducing ITP.
Among reported cases of severe thrombocytopenia asso-
ciated with histoplasmosis, platelet counts often return
to normal levels following antifungal therapy. Therefore,
the most important management of this refractory
thrombocytopenia is the recognition and treatment of
histoplasmosis infection.
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Table 1. Reported cases of disseminated histoplasmosis and thrombocytopenia in immunocompetent adults
References Publication Article summary
Smith and Utz [8] Annals of Internal
Medicine
Among 21 adults with disseminated histoplasmosis, eight (38%) had thrombocytopenia.
Four cases were among immunocompetent adults
Armitage and Sheets
[3]
Journal of the American
Medical Association
A 41-year-old woman who recovered from histoplasmosis but had persistent
thrombocytopenia requiring splenectomy
Goodwin et al. [5] Medicine (Baltimore) Among 84 cases of histoplasmosis reported over 45 years, 21 cases were
immunocompetent adults. Profound thrombocytopenia (<5 k/cumm) occurred in 21% of
patients with severe histoplasmosis, and in 0 patients with mild or moderate disease
Kucera and Davis [6] American Journal of
Clinical Pathology
A 20-year-old woman with thrombocytopenia and IgG elevation in primary pulmonary
histoplasmosis
Hankey and Gulland
[9]
Australia New Zealand
Journal of Medicine
A 45-year-old Burmese man with disseminated histoplasmosis and thrombocytopenia in
Western Australia
Harten et al. [10] Clinical Investigation A 24-year-old woman with disseminated histoplasmosis in an immunocompetent
European woman
Singh et al. [15] Postgraduate Medical
Journal
A 50-year-old male farmer with disseminated histoplasmosis and pancytopenia who
developed bleeding symptoms and expired
Valdivia-Arenas and
Sood Namita [11]
Chest A 77-year-old farmer from Ohio with disseminated histoplasmosis, severe sepsis, and
thrombocytopenia
Deodhar et al. [7] National Medical Journal of
India
Among 61 cases of histoplasmosis in India, 10 cases were immunocompetent adults with
pancytopenia
Subbalaxmi et al. [4] Medical Mycology Case
Reports
A 56-year-old male farmer from southern India with disseminated histoplasmosis,
refractory thrombocytopenia, and bleeding manifestations
Kashif et al. [12] Case Reports Critical Care A 34-year-old man with sickle-cell disease who developed Histoplasma duboisii infection
and did not respond to amphotericin B. He progressed to develop hemophagocytic
lymphocytosis, disseminated intravascular coagulation, and cardiorespiratory arrest
Gajendra et al. [14] Turkish Journal of
Haematology
A 44-year-old man with histoplasmosis, pancytopenia, and bilateral adrenal masses
Elbadawi et al. [17] ID Cases A 65-year-old man with pulmonary sarcoidosis (not taking corticosteroids) who developed
disseminated histoplasmosis with anemia and thrombocytopenia
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